A New Model For Vela Jr. Supernova Remnant

We consider Vela Jr. as being the old Supernova Remnant (SNR) at the beginning of the transition from adiabatic to radiative stage of evolution. According to our model, Vela Jr. is situated outside Vela SNR at the distance of 600 pc and its age is 17500 yr. We model the high energy fluxes from Vela Jr. and its broadband spectrum. We find our results compatible with experimental data in radio waves, X- and gamma-rays. Our hydrodynamical model of Vela Jr. explains the observed TeV gamma-ray flux by hadronic mechanism. The proposed model does not contradict to the low density environment of the SNR and does not need extreme fraction of the explosion energy to be transferred to Cosmic Rays.Comment: Accepted for publication in Astroparticle Physic

Magnetic fields in supernova remnants and pulsar-wind nebulae

We review the observations of supernova remnants (SNRs) and pulsar-wind nebulae (PWNe) that give information on the strength and orientation of magnetic fields. Radio polarimetry gives the degree of order of magnetic fields, and the orientation of the ordered component. Many young shell supernova remnants show evidence for synchrotron X-ray emission. The spatial analysis of this emission suggests that magnetic fields are amplified by one to two orders of magnitude in strong shocks. Detection of several remnants in TeV gamma rays implies a lower limit on the magnetic-field strength (or a measurement, if the emission process is inverse-Compton upscattering of cosmic microwave background photons). Upper limits to GeV emission similarly provide lower limits on magnetic-field strengths. In the historical shell remnants, lower limits on B range from 25 to 1000 microGauss. Two remnants show variability of synchrotron X-ray emission with a timescale of years. If this timescale is the electron-acceleration or radiative loss timescale, magnetic fields of order 1 mG are also implied. In pulsar-wind nebulae, equipartition arguments and dynamical modeling can be used to infer magnetic-field strengths anywhere from about 5 microGauss to 1 mG. Polarized fractions are considerably higher than in SNRs, ranging to 50 or 60% in some cases; magnetic-field geometries often suggest a toroidal structure around the pulsar, but this is not universal. Viewing-angle effects undoubtedly play a role. MHD models of radio emission in shell SNRs show that different orientations of upstream magnetic field, and different assumptions about electron acceleration, predict different radio morphology. In the remnant of SN 1006, such comparisons imply a magnetic-field orientation connecting the bright limbs, with a non-negligible gradient of its strength across the remnant.Comment: 20 pages, 24 figures; to be published in SpSciRev. Minor wording change in Abstrac

Six Years of Chandra Observations of Supernova Remnants

We present a review of the first six years of Chandra X-ray Observatory observations of supernova remnants. From the official "first-light" observation of Cassiopeia A that revealed for the first time the compact remnant of the explosion, to the recent million-second spectrally-resolved observation that revealed new details of the stellar composition and dynamics of the original explosion, Chandra observations have provided new insights into the supernova phenomenon. We present an admittedly biased overview of six years of these observations, highlighting new discoveries made possible by Chandra's unique capabilities.Comment: 82 pages, 28 figures, for the book Astrophysics Update

Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)

Metformin, an oral insulin-sensitizing drug, is actively transported into cells by organic cation transporters (OCT) 1, 2, and 3 (encoded by SLC22A1, SLC22A2, or SLC22A3), which are tissue specifically expressed at significant levels in various organs such as liver, muscle, and kidney. Because metformin does not undergo hepatic metabolism, drug-drug interaction by inhibition of OCT transporters may be important. So far, comprehensive data on the interaction of proton pump inhibitors (PPIs) with OCTs are missing although PPIs are frequently used in metformin-treated patients. Using in silico modeling and computational analyses, we derived pharmacophore models indicating that PPIs (i.e. omeprazole, pantoprazole, lansoprazole, rabeprazole, and tenatoprazole) are potent OCT inhibitors. We then established stably transfected cell lines expressing the human uptake transporters OCT1, OCT2, or OCT3 and tested whether these PPIs inhibit OCT-mediated metformin uptake in vitro. All tested PPIs significantly inhibited metformin uptake by OCT1, OCT2, and OCT3 in a concentration-dependent manner. Half-maximal inhibitory concentration values (IC50) were in the low micromolar range (3–36 µM) and thereby in the range of IC50 values of other potent OCT drug inhibitors. Finally, we tested whether the PPIs are also transported by OCTs, but did not identify PPIs as OCT substrates. In conclusion, PPIs are potent inhibitors of the OCT-mediated metformin transport in vitro. Further studies are needed to elucidate the clinical relevance of this drug-drug interaction with potential consequences on metformin disposition and/or efficacy

ASASSN-15lh: a superluminous ultraviolet rebrightening observed by Swift and Hubble

We present and discuss ultraviolet and optical photometry from the Ultraviolet/Optical Telescope and X-ray limits from the X-Ray Telescope on Swift and imaging polarimetry and ultraviolet/optical spectroscopy with the Hubble Space Telescope of ASASSN-15lh. It has been classified as a hydrogenpoor superluminous supernova (SLSN I) more luminous than any other supernova observed. ASASSN- 15lh is not detected in the X-rays in individual or coadded observations. From the polarimetry we determine that the explosion was only mildly asymmetric. We find the flux of ASASSN-15lh to increase strongly into the ultraviolet, with a ultraviolet luminosity a hundred times greater than the hydrogen-rich, ultraviolet-bright SLSN II SN 2008es. We find objects as bright as ASASSN-15lh are easily detectable beyond redshifts of ∼4 with the single-visit depths planned for the Large Synoptic Survey Telescope. Deep near-infrared surveys could detect such objects past a redshift of ∼20 enabling a probe of the earliest star formation. A late rebrightening – most prominent at shorter wavelengths – is seen about two months after the peak brightness, which is itself as bright as a superluminous supernova. The ultraviolet spectra during the rebrightening are dominated by the continuum without the broad absorption or emission lines seen in SLSNe or tidal disruption events and the early optical spectra of ASASSN-15lh. Our spectra show no strong hydrogen emission, showing only Lyα absorption near the redshift previously found by optical absorption lines of the presumed host. The properties of ASASSN-15lh are extreme when compared to either SLSNe or tidal disruption events

Supernova remnants: the X-ray perspective

Supernova remnants are beautiful astronomical objects that are also of high scientific interest, because they provide insights into supernova explosion mechanisms, and because they are the likely sources of Galactic cosmic rays. X-ray observations are an important means to study these objects.And in particular the advances made in X-ray imaging spectroscopy over the last two decades has greatly increased our knowledge about supernova remnants. It has made it possible to map the products of fresh nucleosynthesis, and resulted in the identification of regions near shock fronts that emit X-ray synchrotron radiation. In this text all the relevant aspects of X-ray emission from supernova remnants are reviewed and put into the context of supernova explosion properties and the physics and evolution of supernova remnants. The first half of this review has a more tutorial style and discusses the basics of supernova remnant physics and thermal and non-thermal X-ray emission. The second half offers a review of the recent advances.The topics addressed there are core collapse and thermonuclear supernova remnants, SN 1987A, mature supernova remnants, mixed-morphology remnants, including a discussion of the recent finding of overionization in some of them, and finally X-ray synchrotron radiation and its consequences for particle acceleration and magnetic fields.Comment: Published in Astronomy and Astrophysics Reviews. This version has 2 column-layout. 78 pages, 42 figures. This replaced version has some minor language edits and several references have been correcte

Inverse Compton X-ray Emission from Supernovae with Compact Progenitors: Application to SN2011fe

We present a generalized analytic formalism for the inverse Compton X-ray emission from hydrogen-poor supernovae and apply this framework to SN2011fe using Swift-XRT, UVOT and Chandra observations. We characterize the optical properties of SN2011fe in the Swift bands and find them to be broadly consistent with a "normal" SN Ia, however, no X-ray source is detected by either XRT or Chandra. We constrain the progenitor system mass loss rate to be lower than 2x10^-9 M_sun/yr (3sigma c.l.) for wind velocity v_w=100 km/s. Our result rules out symbiotic binary progenitors for SN2011fe and argues against Roche-lobe overflowing subgiants and main sequence secondary stars if >1% of the transferred mass is lost at the Lagrangian points. Regardless of the density profile, the X-ray non-detections are suggestive of a clean environment (particle density < 150 cm-3) for (2x10^15<R<5x10^16) cm around the progenitor site. This is either consistent with the bulk of material being confined within the binary system or with a significant delay between mass loss and supernova explosion. We furthermore combine X-ray and radio limits from Chomiuk et al. 2012 to constrain the post shock energy density in magnetic fields. Finally, we searched for the shock breakout pulse using gamma-ray observations from the Interplanetary Network and find no compelling evidence for a supernova-associated burst. Based on the compact radius of the progenitor star we estimate that the shock break out pulse was likely not detectable by current satellites.Comment: Submitted to Ap

Molecular and atomic gas in the young TeV \gamma-ray SNRs RX J1713.7-3946 and RX J0852.0-4622; evidence for the hadronic production of \gamma-rays

The interstellar molecular clouds are the site of star formation and also the target for the cosmic ray protons to produce \gamma-rays via the hadronic process. The interstellar atomic gas is enveloping the molecular clouds and may also be dense enough to affect the \gamma-ray production. In this Chapter, some of the basic properties of the interstellar gas both in molecular and atomic forms will be reviewed. Then, it is presented that two young TeV \gamma-ray SNRs, RX J1713.7-3946 and RX J0852.0-4622, show good spatial correspondence between the \gamma-rays and the interstellar protons. The good spatial correspondence provides a support for the hadronic origin of the \gamma-rays in these SNRs. It is emphasized that both molecular and atomic hydrogen plays a role as targets for cosmic ray (CR) protons. The clumpy distribution of the target interstellar medium (ISM) protons is crucial in the interaction of the supernova shocks with the ISM, whereas models with uniform ISM distribution are not viable. Finally, it is suggested that the dense atomic gas without molecules may occupy the dominant part of the dark gas in the local ISM.Comment: 23 pages, 15 figures, To appear in "Cosmic Rays in Star-Forming Environments: Proceedings of the Second Session of the Sant Cugat Forum on Astrophysics" (April 16-19, 2012), Torres, Diego F. and Reimer, Olaf (Eds.

Nutraceutical therapies for atherosclerosis

Atherosclerosis is a chronic inflammatory disease affecting large and medium arteries and is considered to be a major underlying cause of cardiovascular disease (CVD). Although the development of pharmacotherapies to treat CVD has contributed to a decline in cardiac mortality in the past few decades, CVD is estimated to be the cause of one-third of deaths globally. Nutraceuticals are natural nutritional compounds that are beneficial for the prevention or treatment of disease and, therefore, are a possible therapeutic avenue for the treatment of atherosclerosis. The purpose of this Review is to highlight potential nutraceuticals for use as antiatherogenic therapies with evidence from in vitro and in vivo studies. Furthermore, the current evidence from observational and randomized clinical studies into the role of nutraceuticals in preventing atherosclerosis in humans will also be discussed